Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim Buys Cellomics Automated Cell Imaging Technology

NEW YORK, Aug. 3 – Cellomics has sold its ArrayScan HCS system for imaging cells to Boehringer Ingelheim Pharmaceuticals, Cellomics said on Friday.

The giant German pharma company will use the system to automate its drug-discovery process, the company said in a statement.

Financial details were not disclosed.

The HCS system analyzes how potential drugs affect cells by automatically imaging whether cellular probes fluoresce. The system, which Cellomics said has been placed in nine of the top 10 pharmaceutical companies in the world, is compatible with both 96 and 384 well microtitre plates.

In addition to ArrayScan, Cellomics is also developing other screening and bioinformatics products for cell analysis.  

“Cellomics is very proud to have placed an ArrayScan HCS system in the lab or such a well-respected company,” Cellomics Vice President for Sales Paul Kinnon said in the statement.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.